This happens when someone with fatty liver drinks coffee every day

Coffee has been consistently associated with a reduced risk of chronic liver disease progression and liver-related mortality through multiple well-documented biological mechanisms. Caffeine appears to antagonize adenosine A2a receptors on hepatic stellate cells, which can reduce fibrogenic signaling and collagen production involved in liver scarring. Coffee also supports hepatic antioxidant defenses by increasing glutathione activity and modulating detoxification enzymes such as glutathione S-transferase, while compounds like kahweol and cafestol contribute to these protective enzymatic effects. In addition, coffee polyphenols such as chlorogenic acid help suppress pro-inflammatory cytokine pathways that drive chronic liver injury. Metabolically, coffee consumption has been linked to improved insulin sensitivity and stimulation of autophagy, both of which are important in reducing hepatic fat accumulation and progression of non-alcoholic fatty liver disease. Clinically, regular coffee drinkers tend to show lower serum levels of liver injury markers including ALT, AST, and GGT, which reflect reduced hepatocellular stress. Overall, large-scale evidence supports an association between coffee intake and improved liver outcomes, including reduced fibrosis, cirrhosis, and hepatocellular carcinoma risk.